Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Nastech gets nasal patent rights from Thiakis

Executive Summary

Nasal drug delivery company Nastech Pharmaceutical has acquired rights from UK start-up Thiakis Ltd. (therapeutics for metabolic diseases) to a set of patents for the intranasal delivery of peptide YY 3-36 to treat obesity and other metabolic disorders.
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Nasal
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register